{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T20:08:32Z","timestamp":1791403712889,"version":"4.3.3"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T00:00:00Z","timestamp":1770336000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Hematol"],"DOI":"10.1007\/s00277-026-06859-8","type":"journal-article","created":{"date-parts":[[2026,2,6]],"date-time":"2026-02-06T04:11:29Z","timestamp":1770351089000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Platelet-neutrophil ratio as a potential biomarker for stroke risk stratification in children and young adults with sickle cell anaemia in resource poor settings"],"prefix":"10.1007","volume":"105","author":[{"given":"Chisom Adaobi","family":"Nri-Ezedi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chilota Chibuife","family":"Efobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepika","family":"Darbari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana-Bilkisu","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,6]]},"reference":[{"key":"6859_CR1","unstructured":"Thomson AM, McHugh TA, Oron AP, Teply C, Lonberg N, Vilchis Tella V et al (2023) Global, regional, and national prevalence and mortality burden of sickle cell disease, 2000\u20132021: a systematic analysis from the Global Burden of Disease Study 2021. Lancet Haematol [cited 2023 Jun 20];0. Available from: http:\/\/www.thelancet.com\/article\/S2352302623001187\/fulltext"},{"key":"6859_CR2","doi-asserted-by":"crossref","unstructured":"Makani J, Williams TN, Marsh K (2007) Sickle cell disease in Africa: burden and research priorities. Ann Trop Med Parasitol [cited 2023 Jul 13];101:3\u201314. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/17244405\/","DOI":"10.1179\/136485907X154638"},{"key":"6859_CR3","doi-asserted-by":"crossref","unstructured":"Powars D, Wilson B, Imbus C, Pegelow C, Allen J (1978) The natural history of stroke in sickle cell disease. Am J Med [cited 2023 May 18];65:461\u201371. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/717414\/","DOI":"10.1016\/0002-9343(78)90772-6"},{"key":"6859_CR4","doi-asserted-by":"crossref","unstructured":"Mburu J, Odame I (2019) Sickle cell disease: reducing the global disease burden. Int J Lab Hematol [cited 2023 Jun 20];41 Suppl 1:82\u20138. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/31069977\/","DOI":"10.1111\/ijlh.13023"},{"key":"6859_CR5","first-page":"288","volume":"91","author":"K Ohene-Frempong","year":"1998","unstructured":"Ohene-Frempong K, Weiner SJ, Sleeper LA, Miller ST, Embury S, Moohr JW et al (1998) Cerebrovascular accidents in sickle cell disease: rates and risk factors. Blood 91:288\u2013294","journal-title":"Blood"},{"key":"6859_CR6","doi-asserted-by":"crossref","unstructured":"Adams R, McKie V, Nichols F, Carl E, Zhang DL, McKie K et al (1992) The use of transcranial ultrasonography to predict stroke in sickle cell disease. N Engl J Med [cited 2024 Jan 23];326:605\u201310. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/1734251\/","DOI":"10.1056\/NEJM199202273260905"},{"key":"6859_CR7","doi-asserted-by":"crossref","unstructured":"Modebe E, Nonyelu C, Duru A, Ezenwosu O, Chukwu B, Madu A et al (2023) Cerebral artery conditional blood velocity in sickle cell disease: a multicentre study and evidence for active treatment. Arch Dis Child [cited 2024 Jan 23];108:440\u20134. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/36737235\/","DOI":"10.1136\/archdischild-2022-325106"},{"key":"6859_CR8","doi-asserted-by":"crossref","unstructured":"Efobi CC, Nri-Ezedi CA, Madu CS, Ikediashi CC, Ejiofor O, Ofiaeli CI (2023) Neutrophil-lymphocyte platelet-neutrophil, and plateletlymphocyte ratios as indicators of sickle cell anaemia severity. Ethiop J Health Sci [cited 2024 Jan 23];33:821\u201330. Available from: https:\/\/www.ajol.info\/index.php\/ejhs\/article\/view\/255812","DOI":"10.4314\/ejhs.v33i5.12"},{"key":"6859_CR9","doi-asserted-by":"crossref","unstructured":"Chen G, Zhang D, Fuchs TA, Manwani D, Wagner DD, Frenette PS (2014) Heme-induced neutrophil extracellular traps contribute to the pathogenesis of sickle cell disease. Blood [cited 2024 May 25];123:3818\u201327. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/24620350\/","DOI":"10.1182\/blood-2013-10-529982"},{"key":"6859_CR10","doi-asserted-by":"crossref","unstructured":"Lum AFH, Wun T, Staunton D, Simon SI (2004) Inflammatory potential of neutrophils detected in sickle cell disease. Am J Hematol [cited 2023 May 22];76:126\u201333. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/15164377\/","DOI":"10.1002\/ajh.20059"},{"key":"6859_CR11","doi-asserted-by":"crossref","unstructured":"Zhang D, Xu C, Manwani D, Frenette PS (2016) Neutrophils, platelets, and inflammatory pathways at the nexus of sickle cell disease pathophysiology. Blood [cited 2024 May 25];127:801\u20139. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/26758915\/","DOI":"10.1182\/blood-2015-09-618538"},{"key":"6859_CR12","doi-asserted-by":"crossref","unstructured":"Westerman MP, Green D, Gilman-Sachs A, Beaman K, Freels S, Boggio L et al (1999) Antiphospholipid antibodies, proteins C and S, and coagulation changes in sickle cell disease. J Lab Clin Med [cited 2024 May 25];134:352\u201362. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/10521081\/","DOI":"10.1016\/S0022-2143(99)90149-X"},{"key":"6859_CR13","doi-asserted-by":"crossref","unstructured":"Proenca\u0327-Ferreira R, Brugnerotto AF, Garrido VT, Dominical VM, Vital DM, Ribeiro MFR et al Endothelial Activation by Platelets from Sickle Cell Anemia Patients. PLoS One [Internet] 2014 [cited 2024 May 25];9:e89012. Available from: https:\/\/journals.plos.org\/plosone\/article?id=10.1371\/journal.pone.0089012","DOI":"10.1371\/journal.pone.0089012"},{"key":"6859_CR14","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.3324\/haematol.2014.108555","volume":"99","author":"VM Dominical","year":"2014","unstructured":"Dominical VM, Samse L, Nichols JS, Costa FF, McCoy JP, Conran N et al (2014) Prominent role of platelets in the formation of Circulating neutrophil-red cell heterocellular aggregates in sickle cell anemia. Haematologica 99:e214\u2013e217","journal-title":"Haematologica"},{"key":"6859_CR15","doi-asserted-by":"publisher","first-page":"2392","DOI":"10.1161\/ATVBAHA.110.211615","volume":"30","author":"R Polanowska-Grabowska","year":"2010","unstructured":"Polanowska-Grabowska R, Wallace K, Field JJ, Chen L, Marshall MA, Figler R et al (2010) P-selectin-mediated platelet-neutrophil aggregate formation activates neutrophils in mouse and human sickle cell disease. Arterioscler Thromb Vasc Biol 30:2392\u20132399","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"6859_CR16","doi-asserted-by":"crossref","unstructured":"Grosse SD, Odame I, Atrash HK, Amendah DD, Piel FB, Williams TN (2011) Sickle cell disease in Africa: A neglected cause of early childhood mortality. Am J Prev Med 41","DOI":"10.1016\/j.amepre.2011.09.013"},{"key":"6859_CR17","unstructured":"Osei MA, McGann PT (2023) Sickle cell disease: time to act on the most neglected global health problem. Lancet Haematol [cited 2023 Jun 20];0. Available from: http:\/\/www.thelancet.com\/article\/S2352302623001692\/fulltext"},{"key":"6859_CR18","doi-asserted-by":"crossref","unstructured":"Ware RE, Helms RW (2012) Stroke with transfusions changing to hydroxyurea (SWiTCH). Blood [cited 2023 May 18];119:3925\u201332. Available from: https:\/\/pubmed.ncbi.nlm.nih.gov\/22318199\/","DOI":"10.1182\/blood-2011-11-392340"},{"key":"6859_CR19","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1177\/088307380001500511","volume":"15","author":"RJ Adams","year":"2000","unstructured":"Adams RJ (2000) Lessons from the stroke prevention trial in sickle cell anemia (STOP) study. J Child Neurol 15:344\u2013349","journal-title":"J Child Neurol"}],"container-title":["Annals of Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00277-026-06859-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00277-026-06859-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T16:05:55Z","timestamp":1771949155000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00277-026-06859-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,6]]},"references-count":19,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2026,3]]}},"alternative-id":["6859"],"URL":"https:\/\/doi.org\/10.1007\/s00277-026-06859-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7557167\/v1","asserted-by":"object"}]},"ISSN":["1432-0584"],"issn-type":[{"value":"1432-0584","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,6]]},"assertion":[{"value":"7 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval for the study was obtained from the institutional review board (IRB) at Children's National Hospital, Washington DC, United States of America. IRB number: Pro00010744","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"Ethical approval for the study was obtained from the Institutional Review Board (IRB) of Children\u2019s National Hospital, Washington, D.C., USA (IRB number: Pro00010744). As this was a retrospective chart review using de-identified data, individual patient consent was waived by the IRB in accordance with ethical regulations and the principles outlined in the Declaration of Helsinki.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human ethics and consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"92"}}